Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Periods of high dengue transmission defined by rainfall do not impact efficacy of dengue vaccine in regions of endemic disease.

Pasin C, Halloran ME, Gilbert PB, Langevin E, Ochiai RL, Pitisuttithum P, Capeding MR, Carrasquilla G, Frago C, Cortés M, Chambonneau L, Moodie Z.

PLoS One. 2018 Dec 13;13(12):e0207878. doi: 10.1371/journal.pone.0207878. eCollection 2018.

2.

Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries.

Nealon J, Taurel AF, Yoksan S, Moureau A, Bonaparte M, Quang LC, Capeding MR, Prayitno A, Hadinegoro SR, Chansinghakul D, Bouckenooghe A.

J Infect Dis. 2019 Jan 9;219(3):375-381. doi: 10.1093/infdis/jiy513.

3.

Health-related quality of life, temperament, and eating behavior among formula-fed infants in the Philippines: a pilot study.

Volger S, Estorninos EM, Capeding MR, Lebumfacil J, Radler DR, Scott Parrott J, Rothpletz-Puglia P.

Health Qual Life Outcomes. 2018 Jun 8;16(1):121. doi: 10.1186/s12955-018-0944-5.

4.

Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: Phase I trial in Healthy Filipino adults and children.

Capeding MR, Teshome S, Saluja T, Syed KA, Kim DR, Park JY, Yang JS, Kim YH, Park J, Jo SK, Chon Y, Kothari S, Yang SY, Ham DS, Ryu JH, Hwang HS, Mun JH, Lynch JA, Kim JH, Kim H, Excler JL, Sahastrabuddhe S.

Vaccine. 2018 Jun 18;36(26):3794-3801. doi: 10.1016/j.vaccine.2018.05.038.

5.

Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines.

Capeding MR, Alberto ER, Bouckenooghe A, Laot TM, Chansinghakul D, Monfredo C, Machabert T, Feroldi E.

J Infect Dis. 2018 Jan 30;217(4):567-571. doi: 10.1093/infdis/jix601.

6.

Controversy and debate on dengue vaccine series-paper 2: response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs.

Hadinegoro SRS, Arredondo-García JL, Capeding MR, Pallardy S, Noriega F, Bouckenooghe A.

J Clin Epidemiol. 2018 Mar;95:140-141. doi: 10.1016/j.jclinepi.2017.12.024. Epub 2018 Jan 3. No abstract available.

PMID:
29306062
7.

Safety and immunogenicity of the killed bivalent (O1 and O139) whole-cell cholera vaccine in the Philippines.

Capeding MRZ, Gonzales MLAM, Dhingra MS, D'Cor NA, Midde VJ, Patnaik BN, Thollot Y, Desauziers E.

Hum Vaccin Immunother. 2017 Oct 3;13(10):2232-2239. doi: 10.1080/21645515.2017.1342908.

8.

Three Decades of Dengue Surveillance in Five Highly Endemic South East Asian Countries.

Wartel TA, Prayitno A, Hadinegoro SR, Capeding MR, Thisyakorn U, Tran NH, Moureau A, Bouckenooghe A, Nealon J, Taurel AF.

Asia Pac J Public Health. 2017 Jan;29(1):7-16. doi: 10.1177/1010539516675701. Epub 2016 Nov 15. Review.

PMID:
28198645
9.

Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization.

Kosalaraksa P, Watanaveeradej V, Pancharoen C, Capeding MR, Feroldi E, Bouckenooghe A.

Pediatr Infect Dis J. 2017 Apr;36(4):e108-e113. doi: 10.1097/INF.0000000000001494.

PMID:
28030526
10.

Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial.

Nealon J, Taurel AF, Capeding MR, Tran NH, Hadinegoro SR, Chotpitayasunondh T, Chong CK, Wartel TA, Beucher S, Frago C, Moureau A, Simmerman M, Laot T, L'Azou M, Bouckenooghe A.

PLoS Negl Trop Dis. 2016 Aug 17;10(8):e0004918. doi: 10.1371/journal.pntd.0004918. eCollection 2016 Aug.

11.

Impact of long-term use of oral nutritional supplement on nutritional adequacy, dietary diversity, food intake and growth of Filipino preschool children.

Huynh DT, Estorninos E, Capeding MR, Oliver JS, Low YL, Rosales FJ.

J Nutr Sci. 2016 May 13;5:e20. doi: 10.1017/jns.2016.6. eCollection 2016.

12.

Symptomatic Dengue in Children in 10 Asian and Latin American Countries.

L'Azou M, Moureau A, Sarti E, Nealon J, Zambrano B, Wartel TA, Villar L, Capeding MR, Ochiai RL; CYD14 Primary Study Group; CYD15 Primary Study Group.

N Engl J Med. 2016 Mar 24;374(12):1155-66. doi: 10.1056/NEJMoa1503877.

13.
14.

Safety and tolerability of a cell culture derived trivalent subunit inactivated influenza vaccine administered to healthy children and adolescents: A Phase III, randomized, multicenter, observer-blind study.

Nolan T, Chotpitayasunondh T, Capeding MR, Carson S, Senders SD, Jaehnig P, de Rooij R, Chandra R.

Vaccine. 2016 Jan 4;34(2):230-236. doi: 10.1016/j.vaccine.2015.11.040. Epub 2015 Nov 29.

15.

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.

Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cortés M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M; CYD-TDV Dengue Vaccine Working Group.

N Engl J Med. 2015 Sep 24;373(13):1195-206. doi: 10.1056/NEJMoa1506223. Epub 2015 Jul 27.

16.

Laboratory-confirmed Dengue in Children in Three Regional Hospitals in the Philippines in 2009-2010.

Capeding MR, L'Azou M, Manalaysay M, Vince-Woo CR, Rivera RG, Kristy Sy A, Mercado ES, Inobaya MT, Tayag EG.

Pediatr Infect Dis J. 2015 Nov;34(11):1145-51. doi: 10.1097/INF.0000000000000810.

17.

First Experience of Concomitant Vaccination Against Dengue and MMR in Toddlers.

Crevat D, Brion JD, Gailhardou S, Laot TM, Capeding MR.

Pediatr Infect Dis J. 2015 Aug;34(8):884-92. doi: 10.1097/INF.0000000000000752.

PMID:
25966916
18.

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial.

Capeding MR, Tran NH, Hadinegoro SR, Ismail HI, Chotpitayasunondh T, Chua MN, Luong CQ, Rusmil K, Wirawan DN, Nallusamy R, Pitisuttithum P, Thisyakorn U, Yoon IK, van der Vliet D, Langevin E, Laot T, Hutagalung Y, Frago C, Boaz M, Wartel TA, Tornieporth NG, Saville M, Bouckenooghe A; CYD14 Study Group.

Lancet. 2014 Oct 11;384(9951):1358-65. doi: 10.1016/S0140-6736(14)61060-6. Epub 2014 Jul 10.

PMID:
25018116
19.

Factors influencing healthcare utilization among children with pneumonia in Muntinlupa City, the Philippines.

Kim SA, Capeding MR, Kilgore PE.

Southeast Asian J Trop Med Public Health. 2014 May;45(3):727-35.

PMID:
24974657
20.

Effects of term infant formulas containing high sn-2 palmitate with and without oligofructose on stool composition, stool characteristics, and bifidogenicity.

Yao M, Lien EL, Capeding MR, Fitzgerald M, Ramanujam K, Yuhas R, Northington R, Lebumfacil J, Wang L, DeRusso PA.

J Pediatr Gastroenterol Nutr. 2014 Oct;59(4):440-8. doi: 10.1097/MPG.0000000000000443.

21.

Preparing for dengue vaccine introduction in ASEAN countries: recommendations from the first ADVA regional workshop.

Thisyakorn U, Capeding MR, Goh DY, Hadinegoro SR, Ismail Z, Tantawichien T, Yoksan S, Pang T.

Expert Rev Vaccines. 2014 May;13(5):581-7. doi: 10.1586/14760584.2014.907529. Epub 2014 Apr 4. Review.

PMID:
24702301
22.

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.

Bhutta ZA, Capeding MR, Bavdekar A, Marchetti E, Ariff S, Soofi SB, Anemona A, Habib MA, Alberto E, Juvekar S, Khan RM, Marhaba R, Ali N, Malubay N, Kawade A, Saul A, Martin LB, Podda A.

Lancet Infect Dis. 2014 Feb;14(2):119-29. doi: 10.1016/S1473-3099(13)70241-X. Epub 2013 Nov 28.

PMID:
24290843
23.

Interchangeability of Quinvaxem during primary vaccination schedules: results from a phase IV, single-blind, randomized, controlled, single-center, non-inferiority study.

Capeding MR, Jica C, Macura-Biegun A, Rauscher M, Alberto E.

Vaccine. 2014 Feb 7;32(7):888-94. doi: 10.1016/j.vaccine.2013.10.059. Epub 2013 Oct 29.

24.

Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children.

Capeding MR, Chua MN, Hadinegoro SR, Hussain II, Nallusamy R, Pitisuttithum P, Rusmil K, Thisyakorn U, Thomas SJ, Huu Tran N, Wirawan DN, Yoon IK, Bouckenooghe A, Hutagalung Y, Laot T, Wartel TA.

PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2331. doi: 10.1371/journal.pntd.0002331. Print 2013.

25.

Prospective surveillance study of invasive pneumococcal disease among urban children in the Philippines.

Capeding MR, Bravo L, Santos J, Kilgore PE, Kim SA, Balter I, Hubler R, Ye J, Moscariello M.

Pediatr Infect Dis J. 2013 Oct;32(10):e383-9. doi: 10.1097/INF.0b013e318298dfd5.

PMID:
23629024
26.

Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.

Feroldi E, Capeding MR, Boaz M, Gailhardou S, Meric C, Bouckenooghe A.

Hum Vaccin Immunother. 2013 Apr;9(4):889-97. doi: 10.4161/hv.23087. Epub 2013 Feb 26.

27.

Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial.

Feroldi E, Pancharoen C, Kosalaraksa P, Watanaveeradej V, Phirangkul K, Capeding MR, Boaz M, Gailhardou S, Bouckenooghe A.

Hum Vaccin Immunother. 2012 Jul;8(7):929-37. doi: 10.4161/hv.20071. Epub 2012 Jul 1.

PMID:
22777096
28.

Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.

Lam SK, Burke D, Capeding MR, Chong CK, Coudeville L, Farrar J, Gubler D, Hadinegoro SR, Hanna J, Lang J, Lee HL, Leo YS, Luong CQ, Mahoney R, McBride J, Mendez-Galvan J, Ng LC, Nimmannitya S, Ooi EE, Shepard D, Smit J, Teyssou R, Thomas L, Torresi J, Vasconcelos P, Wirawan DN, Yoksan S.

Vaccine. 2011 Nov 28;29(51):9417-22. doi: 10.1016/j.vaccine.2011.08.047. Epub 2011 Aug 22.

29.

Molecular characteristics of extended-spectrum β-lactamases in clinical isolates of Enterobacteriaceae from the Philippines.

Kanamori H, Navarro RB, Yano H, Sombrero LT, Capeding MR, Lupisan SP, Olveda RM, Arai K, Kunishima H, Hirakata Y, Kaku M.

Acta Trop. 2011 Oct-Nov;120(1-2):140-5. doi: 10.1016/j.actatropica.2011.07.007. Epub 2011 Jul 28.

PMID:
21820398
30.

Immunogenicity and safety of a DTaP-IPV//PRP approximately T combination vaccine given with hepatitis B vaccine: a randomized open-label trial.

Capeding MR, Cadorna-Carlos J, Book-Montellano M, Ortiz E.

Bull World Health Organ. 2008 Jun;86(6):443-51.

31.

Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.

Forrest BD, Pride MW, Dunning AJ, Capeding MR, Chotpitayasunondh T, Tam JS, Rappaport R, Eldridge JH, Gruber WC.

Clin Vaccine Immunol. 2008 Jul;15(7):1042-53. doi: 10.1128/CVI.00397-07. Epub 2008 Apr 30.

32.

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.

Tam JS, Capeding MR, Lum LC, Chotpitayasunondh T, Jiang Z, Huang LM, Lee BW, Qian Y, Samakoses R, Lolekha S, Rajamohanan KP, Narayanan SN, Kirubakaran C, Rappaport R, Razmpour A, Gruber WC, Forrest BD; Pan-Asian CAIV-T Pediatric Efficacy Trial Network.

Pediatr Infect Dis J. 2007 Jul;26(7):619-28.

PMID:
17596805
33.

Blood culture confirmed typhoid fever in a provincial hospital in the Philippines.

Abucejo PE, Capeding MR, Lupisan SP, Arcay J, Sombrero LT, Ruutu P, Herva E.

Southeast Asian J Trop Med Public Health. 2001 Sep;32(3):531-6.

PMID:
11944712
34.

Invasive bacterial infections of children in a rural province in the central Philippines.

Lupisan SP, Herva E, Sombrero LT, Quiambao BP, Capeding MR, Abucejo PE, Esparar G, Arcay J, Ruutu P.

Am J Trop Med Hyg. 2000 Mar;62(3):341-6.

PMID:
11037775
35.

Effect of transplacentally acquired tetanus antibodies on the antibody responses to Haemophilus influenzae type b-tetanus toxoid conjugate and tetanus toxoid vaccines in Filipino infants.

Nohynek H, Gustafsson L, Capeding MR, Käyhty H, Olander RM, Pascualk L, Ruutu P.

Pediatr Infect Dis J. 1999 Jan;18(1):25-30.

PMID:
9951976
36.

Antibody responses of three Haemophilus influenzae type b conjugate vaccines after one, two and three doses in Filipino children.

Capeding MR, Nohynek H, Käyhty H, Pascual LG, Sunico ES, Tamundong AA, Ruutu P.

Vaccine. 1998 May-Jun;16(9-10):1004-8.

PMID:
9682351
37.

Dengue surveillance in Metro Manila.

Capeding MR, Paladin FJ, Miranda EG, Navarro XR.

Southeast Asian J Trop Med Public Health. 1997 Sep;28(3):530-4.

PMID:
9561603
38.

The immunogenicity of three Haemophilus influenzae type B conjugate vaccines after a primary vaccination series in Philippine infants.

Capeding MR, Nohynek H, Pascual LG, Kayhty H, Sombrero LT, Eskola J, Ruutu P.

Am J Trop Med Hyg. 1996 Nov;55(5):516-20.

PMID:
8940983
39.

Evaluation of sampling sites for detection of upper respiratory tract carriage of Streptococcus pneumoniae and Haemophilus influenzae among healthy Filipino infants.

Capeding MR, Nohynek H, Sombrero LT, Pascual LG, Sunico ES, Esparar GA, Esko E, Leinonen M, Ruutu P.

J Clin Microbiol. 1995 Nov;33(11):3077-9.

40.

Etiology of acute lower respiratory infection in Filipino children under five years.

Capeding MR, Sombrero LT, Paladin FJ, Suzuki H, Numazaki Y, Saniel MC.

Southeast Asian J Trop Med Public Health. 1994 Dec;25(4):684-7.

PMID:
7667713
41.

Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Filipino children.

Capeding MR, Sombrero LT, Lucero MG, Saniel MC.

J Infect Dis. 1994 Feb;169(2):479-80. No abstract available.

PMID:
8106791
42.

Pre-discharge immunization among hospitalized Filipino children.

Capeding MR, Lazaro JA, Kaneko YY.

Pediatr Infect Dis J. 1990 Aug;9(8):570-3.

PMID:
2235173

Supplemental Content

Loading ...
Support Center